Guiu, Boris http://orcid.org/0000-0003-1277-3054
Garin, Etienne
Allimant, Carole
Edeline, Julien
Salem, Riad
Article History
Received: 8 November 2021
Accepted: 23 January 2022
First Online: 11 February 2022
Declarations
:
: Boris Guiu is consultant to Boston Scientific. Etienne Garin is consultant to Boston Scientific and reports receiving a grant, personal fees, and non-financial support from Boston Scientific. Julien Edeline reports receiving a grant from Boston Scientific; personal fees from Boston Scientific, Bayer, Roche, Eisai, Merck Sharpe and Dohme, AstraZeneca, and Ipsen; grants and personal fees from Bristol Myers Squibb; and non-financial support from Amgen, outside the submitted work. Riad Salem is a consultant to Boston Scientific, Bard, Sirtex, Eisai, Astrazeneca, Cook, Siemens and Genentech.
: For this type of study consent for publication is not required.
: This article does not contain any studies with human participants or animals performed by any of the authors
: For this type of study informed consent is not required